Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Dabigatran Etexilate in Patients With Atrial Fibrillation After Mitral Valve Prosthetic Replacement

NCT03183843 is registered in ClinicalTrials.gov with Research Institute for Complex Problems of Cardiovascular Diseases, Russia as lead sponsor.

NCT NCT03183843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Dabigatran Etexilate in Patients With Atrial Fibrillation After Mitral Valve Prosthetic Replacement
Lead sponsor
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Phase
Phase 4
Overall status
Unknown status
Start date
June 29, 2016
Completion date
December 1, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, mitral valve stenosis and insufficiency